NCT04962932

Brief Summary

The aim of this study is to evaluate if internet- delivered cognitive behavior therapy (CBT), based on exposure principles and behavioral activation, improves QoL and symptom burden in patients with symptomatic atrial fibrillation (AF), controlling for expectancy of improvement and attention from a caregiver, using an active control group (stress management). The study will include 260 patients with symptomatic AF despite optimal medical treatment in accordance with current guidelines.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
206

participants targeted

Target at P50-P75 for not_applicable atrial-fibrillation

Timeline
Completed

Started Aug 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 24, 2021

Completed
21 days until next milestone

First Posted

Study publicly available on registry

July 15, 2021

Completed
29 days until next milestone

Study Start

First participant enrolled

August 13, 2021

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 5, 2023

Completed
Last Updated

October 11, 2023

Status Verified

October 1, 2023

Enrollment Period

1.6 years

First QC Date

June 24, 2021

Last Update Submit

October 10, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Atrial Fibrillation Effect on Quality-of-Life modified for weekly assessment

    The AFEQT is an atrial fibrillation-specific measure that taps into the QoL-domains: symptoms, daily activities, treatment concern, and treatment satisfaction. Total score ranges from 0 (severe symptoms and disability) to 100 (no symptoms and disability).

    Change over 11 measurement points measured from baseline and weekly for 10 weeks during treatment [PRIMARY ENDPOINT]

  • Atrial Fibrillation Effect on Quality-of-Life modified for weekly assessment

    The AFEQT is an atrial fibrillation-specific measure that taps into the QoL-domains: symptoms, daily activities, treatment concern, and treatment satisfaction. Total score ranges from 0 (severe symptoms and disability) to 100 (no symptoms and disability).

    From baseline to 9 months

Secondary Outcomes (30)

  • Cardiac Anxiety Questionnaire (CAQ)

    From baseline to 10 weeks

  • Cardiac Anxiety Questionnaire (CAQ)

    From baseline to 9 months

  • AF-avoidance behavior questionnaire

    From baseline to 10 weeks

  • AF-avoidance behavior questionnaire

    From baseline to 9 months

  • AF-avoidance behavior questionnaire modified for weekly assessment

    Change over 11 measurement points measured from baseline and weekly for 10 weeks during treatment

  • +25 more secondary outcomes

Other Outcomes (7)

  • Psychosocial stressors and changes in physical health

    10 weeks from baseline

  • Psychosocial stressors and changes in physical health

    9 months from baseline

  • Background data

    Baseline

  • +4 more other outcomes

Study Arms (2)

Internet-delivered exposure-focused CBT

EXPERIMENTAL

Internet-delivered CBT over 10 weeks The CBT treatment lasts for 10 weeks and includes the following: Education on the role of anxiety on cardiac function and the effects of symptom preoccupation and avoidance QoL and depression in AF, creating a vicious cycle; exposure to physical sensations that are similar to AF symptoms (e.g.,palpitations due to physical activity or stress) to reduce fear of these symptoms; exposure to situations or activities previously avoided and abolishment of behaviors that aim to control symptoms; and behavioral activation aiming to increase social and physical activity and reduce depressive symptoms. Therapist support is provided at least once weekly through the platform developed for the purpose. Therapists are trained CBT-psychologists.

Behavioral: Internet-deliviered exposure-based CBT

Internet-delivered stress management treatment

ACTIVE COMPARATOR

Stress management treatment for 10 weeks Participants randomized to The Stress Management Treatment will receive 10 weeks of stress managemen including relaxation technics, standard life style advice regarding physical activity, sleep and and standardized AF-information in line with current guidelines for AF. Therapist support is provided at least once weekly through the platform developed for the purpose. Therapists are trained CBT-psychologists.

Behavioral: Internet-delivered stress management treatment

Interventions

The intervention lasts for 10 weeks and include: Education, Interoceptive exposure, exposure in-vivo, combining in-vivo exposure with interoceptive exposure, behavioral activation and relapse prevention. Include the guidance of a minimum weekly contact with a CBT psychologist.

Internet-delivered exposure-focused CBT

The intervention last for 10 weeks and include: Internet-SMT include life-style advice (e.g., exercise, sleep advice), relaxation and problem-solving skills to reduce stress. Patients are offered regular online contact with a psychologist with the same frequency and intensity as in the CBT arm.

Internet-delivered stress management treatment

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Paroxysmal AF ≥ once per month that causes moderate to severe symptoms and leads to significant distress or interferes with daily life (i.e. EHRA class ≥ IIb);
  • Scoring ≥ 20 on the Cardiac Anxiety Questionnaire at screening;
  • Age 18-75 years;
  • On optimal medical treatment;
  • Able to read and write in Swedish.

You may not qualify if:

  • Heart failure with severe systolic dysfunction (ejection fraction ≤ 35%);
  • Significant valvular disease;
  • Planned ablation for AF or ablation within 3 months before assessment;
  • Other severe medical illness;
  • Any medical restriction to physical exercise;
  • Severe psychiatric disorder, severe depression, or risk of suicide;
  • Alcohol dependency;
  • Previous participation in any AF-CBT study conducted by the research group.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karolinska universitetssjukhuset Solna

Solna, 171 64, Sweden

Location

MeSH Terms

Conditions

Atrial FibrillationArrhythmias, Cardiac

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Brjann Ljotsson, PhD

    Karolinska Institutet

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor,PhD, Lic. psychologist

Study Record Dates

First Submitted

June 24, 2021

First Posted

July 15, 2021

Study Start

August 13, 2021

Primary Completion

March 31, 2023

Study Completion

October 5, 2023

Last Updated

October 11, 2023

Record last verified: 2023-10

Locations